Global healthcare buyout activity rebounded in 2024 after a weaker 2023, returning to its long-term trajectory as economic conditions improved and sponsors sought diversification. Deal momentum showed signs of life particularly in North America, while India and Japan led activity in Asia-Pacific. Healthcare IT saw a notable revival, although limited exits in the first half of 2024 underscored the importance of clear value-creation strategies. Lower interest rates and easing inflation point to stronger dealmaking ahead, though geopolitical tensions and the upcoming US elections could temper investor confidence and slow market enthusiasm.

Join for free to read